SNCA and Parkinson disease: Recent findings by Sekiya, et al. (2022) [36] further highlight the widespread presence of α-synuclein oligomers in various brain regions of PD patients, especially in the neocortex, and their association with cognitive impairment, suggesting their potential significance in early PD pathology.